3D-printed drug/cell carrier enabling effective release of cyclosporin a for xenogeneic cell-based therapy

Cell Transplantation

Volumn 24, Issue 12, 2015, Pages 2513-2525

  Song, Tae Ha ^a,b   Jang, Jinah ^a   Choi, Yeong Jin ^a   Shim, Jin Hyung ^c   Cho, Dong Woo ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b New Drug Development Center   (South Korea)

^c Korea Polytechnic University   (South Korea)

Author keywords

3d printing; Cell based therapy; Cyclosporin a; Drug delivery system; T cell mediated rejection

Indexed keywords

CONCANAVALIN A; CYCLOSPORIN A; DRUG CARRIER; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2; MICROSPHERE; POLYGLACTIN; CYCLOSPORIN; CYTOKINE; HYDROGEL; IMMUNOSUPPRESSIVE AGENT; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CELL TRANSPLANTATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY TEST; DRUG DELIVERY SYSTEM; ENCAPSULATION; FORCE; HUMAN; HUMAN CELL; HYDROGEL; IMMUNOSUPPRESSIVE TREATMENT; IMPLANTATION; IN VITRO STUDY; MALE; MOUSE; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; SUSTAINED DRUG RELEASE; THREE DIMENSIONAL PRINTING; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CYTOLOGY; FIBROBLAST; LUNG; METABOLISM; PHARMACOLOGY; SPLEEN; SYNTHESIS; TRANSPLANTATION; XENOGRAFT;

ANIMALS; CELLS, CULTURED; CYCLOSPORINE; CYTOKINES; DRUG CARRIERS; FIBROBLASTS; HUMANS; HYDROGEL; IMMUNOSUPPRESSIVE AGENTS; LACTIC ACID; LUNG; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROSPHERES; POLYGLYCOLIC ACID; PRINTING, THREE-DIMENSIONAL; SPLEEN; TRANSPLANTATION, HETEROLOGOUS;

EID: 84949800193     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368915X686779     Document Type: Article

References (51)

1. Aksungur, P.; Demirbilek, M.; Denkbas¸, E. B.; Vandervoort, J.; Ludwig, A.; Ünlü, N. Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies. J. Control. Release 151(3):286–294; 2011.
2. Atalar, K.; Afzali, B.; Lord, G.; Lombardi, G. Relative roles of Th1 and Th17 effector cells in allograft rejection. Curr. Opin. Organ Transpl. 14(1):23–29; 2009.
3. Baran, D. A. Opinion: New directions in immunosuppression after heart transplantation. Nat. Rev. Cardiol. 10(7):422–427;2013.
4. Bauer, D.; Wasmuth, S.; Hennig, M.; Baehler, H.; Steuhl, K.-P.; Heiligenhaus, A. Amniotic membrane transplantation induces apoptosis in T lymphocytes in murine corneas with experimental herpetic stromal keratitis. Invest. Ophthalmol. Vis. Sci. 50(7):3188–3198; 2009.
5. Berkland, C.; King, M.; Cox, A.; Kim, K. K.; Pack, D. W. Precise control of PLG microsphere size provides enhanced control of drug release rate. J. Control. Release 82(1):137–147; 2002.
6. Bobadilla, N. A.; Gamba, G. New insights into the pathophysiology of cyclosporine nephrotoxicity: A role of aldosterone. Am. J. Physiol. 293(1):F2–F9; 2007.
7. Caicco, M. J.; Cooke, M. J.; Wang, Y. F.; Tuladhar, A.; Morshead, C. M.; Shoichet, M. S. A hydrogel composite system for sustained epi-cortical delivery of Cyclosporin A to the brain for treatment of stroke. J. Control. Release 166(3):197–202; 2013.
8. Chatterjee, A.; Bindu Sri, M.; Ashok, V. As a review on hydrogels as drug delivery in the pharmaceutical field. Int. J. Pharm. Chem. Sci. 1(2):20; 2012.
9. Daley, G. Q.; Scadden, D. T. Prospects for stem cell-based therapy. Cell 132(4):544–548; 2008.10.
10. Delios, M.; Josien, R.; Manghetti, M.; Amedei, A.; deCarli, M.; Cuturi, M. C.; Blancho, G.; Buzelin, F.; delPrete, G.; Soulillou, J. P. Predominant Th1 cell infiltration in acute rejection episodes of human kidney grafts. Kidney Int. 51(6):1876–1884;1997.
11. Dimmeler, S.; Burchfield, J.; Zeiher, A. M. Cell-based therapy of myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 28(2):208–216; 2008.
12. Farini, A.; Razini, P.; Erratico, S.; Torrente, Y.; Meregalli, M. Cell based therapy for Duchenne muscular dystrophy. J. Cell. Physiol. 221(3):526–534; 2009.
13. Gao, S. Q.; Maeda, T.; Okano, K.; Palczewski, K. A microparticle/hydrogel combination drug-delivery system for sustained release of retinoids. Invest. Ophthalmol. Vis. Sci. 53(10):6314–6323; 2012.
14. Gauthier, P.; Helderman, J. H. Cyclosporine avoidance. J. Am. Soc. Nephrol. 11(10):1933–1936; 2000.
15. Gong, J. P.; Katsuyama, Y.; Kurokawa, T.; Osada, Y. Double-network hydrogels with ;extremely high mechanical strength. Adv. Mater. 15(14):1155–1158; 2003.
16. Harris, R.; Lecumberri, E.; Heras, A. Chitosan-genipin microspheres for the controlled release of drugs: Clarithromycin, tramadol and heparin. Mar. Drugs 8(6): 1750–1762; 2010.
17. He, Y.; Liu, Y. L.; Liu, Y.; Wang, J. C.; Zhang, X.; Lu, W. L.; Ma, Z. Z.; Zhu, X. A.; Zhang, Q. Cyclosporine-loaded microspheres for treatment of uveitis: In vitro characterization and in vivo pharmacokinetic study. Invest. Ophthalmol. Vis. Sci. 47(9):3983–3988; 2006.
18. Hoare, T. R.; Kohane, D. S. Hydrogels in drug delivery: Progress and challenges. Polymer 49(8):1993–2007;2008.
19. Holan, V.; Chudickova, M.; Trosan, P.; Svobodova, E.; Krulova, M.; Kubinova, S.; Sykova, E.; Sirc, J.; Michalek, J.; Juklickova, M; Munzarova, M.; Zajicova, A. Cyclosporine A-loaded and stem cell-seeded electrospun nanofibers for cell-based therapy and local immunosuppression. J. Control Release 156(3):406–412; 2011.
20. Hong, J. C.; Kahan, B. D. Immunosuppressive agents in organ transplantation: Past, present, and future. Semin. Nephrol. 20(2):108–125; 2000.
21. Jain, S.; Mittal, A.; Jain, A. K.; Mahajan, R. R.; Singh, D. Cyclosporin A Loaded PLGA nanoparticle: Preparation, optimization, in-vitro characterization and stability studies. Curr.Nanosci. 6(4):422–431; 2010.
22. Joung, Y. K.; Choi, J. H.; Park, K. M.; Park, K. D. PLGA microparticle-embedded thermosensitive hydrogels for sustained release of hydrophobic drugs. Biomed. Mater. 2(4):269–273; 2007.
23. Kuo, C. K.; Ma, P. X. Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: Part 1. Structure, gelation rate and mechanical properties. Biomaterials 22(6):511–521;2001.
24. Kwan, M. D.; Slater, B. J.; Wan, D. C.; Longaker, M. T. Cell-based therapies for skeletal regenerative medicine. Hum. Mol. Gen. 17(6):R93-R98; 2008
25. Lechler, R. I.; Sykes, M.; Thomson, A. W.; Turka, L. A. Organ transplantation - How much of the promise has been realized? Nat. Med. 11(6):605–613; 2005.
26. Lindvall, O.; Kokaia, Z.; Martinez-Serrano, A. Stem cell therapy for human neurodegenerative disorders–How to make it work. Nat. Med. 10:S42–S50; 2004.
27. Mascarell, L.; Auger, R.; Kanellopoulos, J. M.; Truffa-Bachi, P. The usage of alternative splice sites in Mus musculus synaptotagmin-like 2 gene is modulated by cyclosporine A and FK506 in T-lymphocytes. Mol. Immunol. 43(11):1846–1854; 2006.
28. Matsuda, S.; Koyasu, S. Mechanisms of action of cyclosporine. Int. Immunopharmacol. 47(2–3):119–125; 2000.
29. Mobasheri, A.; Kalamegam, G.; Musumeci, G.; Batt, M. E. Chondrocyte and mesenchymal stem cell-based therapies for cartilage repair in osteoarthritis and related orthopaedic conditions. Maturitas 78(3):188–198; 2014.
30. Myung, D.; Waters, D.; Wiseman, M.; Duhamel, P. E.; Noolandi, J.; Ta, C. N.; Frank, C. W. Progress in the development of interpenetrating polymer network hydrogels. Polym. Adv. Tech. 19(6):647–657; 2008.
31. Naficy, S.; Kawakami, S.; Sadegholvaad, S.; Wakisaka, M.; Spinks, G. M. Mechanical properties of interpenetrating polymer network hydrogels based on hybrid ionically and covalently crosslinked networks. J. Appl. Polym. Sci. 130(4):2504–2513; 2013.
32. Nussenblatt, R. B.; Dinning, W. J.; Fujikawa, L. S.; Chan, C.-C.; Palestine, A. G. Local cyclosporine therapy for experimental autoimmune uveitis in rats. Arch. Ophthalmol. 103(10):1559; 1985.
33. Pei, C.; Xu, Y.; Jiang, J. X.; Cui, L.-J.; Li, L.; Qin, L. Application of sustained delivery microsphere of cyclosporine A for preventing posterior capsular opacification in rabbits. Int. J. Ophthalmol. 6(1):1; 2013.
34. Richer, S.; Judd, N.; Camp, S.; Doerschuk, C. Microsphere phagocytosis by alveolar macrophages in neonatal mice and the role of TNF-alpha signaling. FASEB J. 15(4):A243–A243; 2001.
35. Roelofs, A.; Rocke, J.; De Bari, C. Cell-based approaches to joint surface repair: A research perspective. Osteoarthr. Cartil. 21(7):892–900; 2013.
36. Sa, M.-W.; Kim, J. Y. Effect of various blending ratios on the cell characteristics of PCL and PLGA scaffolds fabricated by polymer deposition system. Int. J. Precis. Eng. Man. 14(4):649–655; 2013.
37. Saralidze, K.; Koole, L. H.; Knetsch, M. L. W. Polymeric microspheres for medical applications. Materials 3(6): 3537–3564; 2010.
38. Seol, Y.-J.; Kang, T.-Y.; Cho, D.-W. Solid freeform fabrication technology applied to tissue engineering with various biomaterials. Soft Matter 8(6):1730–1735; 2012.
39. Shim, J. H.; Kim, J. Y.; Park, M.; Park, J.; Cho, D. W. Development of a hybrid scaffold with synthetic biomaterials and hydrogel using solid freeform fabrication technology. Biofabrication 3(3):034102; 2011.
40. Shim, J. H.; Lee, J. S.; Kim, J. Y.; Cho, D. W. Bioprinting of a mechanically enhanced three-dimensional dual cellladen construct for osteochondral tissue engineering using a multi-head tissue/organ building system. J. Micromech. Microeng. 22(8):085014; 2012.
41. Shim, J.-H.; Moon, T.-S.; Yun, M.-J.; Jeon, Y.-C.; Jeong, C.-M.; Cho, D.-W.; Huh, J.-B. Stimulation of healing within a rabbit calvarial defect by a PCL/PLGA scaffold blended with TCP using solid freeform fabrication technology. J. Mater. Sci. Mater. Med. 23(12):2993–3002; 2012.
42. So, J. W.; Kim, S. H.; Baek, M. O.; Lim, J. Y.; Roh, H. W.; Lee, N. R.; Kim, M. S.; Ryu, G. H.; Cho, Y.-H.; Lee, S. J.; Min, B. H., Khang, G.; Le, H. B. Effect of size of PLGA microsphere on proliferation and phenotype for human intervertebral disc cells. Tissue Eng. Regen. Med. 4(4):577–582; 2007.
43. Tanabe, K. Calcineurin inhibitors in renal transplantation -What is the best option? Drugs 63(15):1535–1548; 2003.
44. Wang, X. Q.; Dai, J. D.; Chen, Z.; Zhang, T.; Xia, G. M.; Nagai, T.; Zhang, Q. Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration. J. Control. Release 97(3):421–429;2004.
45. Wei, A.; Tao, H.; Chung, S. A.; Brisby, H.; Ma, D. D.; Diwan, A. D. The fate of transplanted xenogeneic bone marrow- derived stem cells in rat intervertebral discs. J. Orthop. Res.27(3):374–379; 2009.
46. Wu, Y. J.; Yao, J.; Zhou, J. P.; Dahmani, F. Z. Enhanced and sustained topical ocular delivery of cyclosporine A in thermosensitive hyaluronic acid-based in situ forming microgels. Int. J. Nanomedicine 8:3587–3601; 2013.
47. Xu, T.; Binder, K. W.; Albanna, M. Z.; Dice, D.; Zhao, W.; Yoo, J. J.; Atala, A. Hybrid printing of mechanically and biologically improved constructs for cartilage tissue engineering applications. Biofabrication 5(1):015001; 2013.
48. Yang, Y.-G. Application of xenogeneic stem cells for induction of transplantation tolerance: Present state and future directions. Springer Semin. Immunopathol. 26:187–200;2004.
49. Yu, X.; Jiang, Y. F.; Lu, L.; Gong, X.; Sun, X. G.; Xuan, Z. P.; Lu, L. J. A crucial role of IL-17 and IFN-gamma during acute rejection of peripheral nerve xenotransplantation in mice. Plos One 7(3):e34419; 2012.
50. Zhang, H.; Zhu, S.; Wang, W.; Wei, Y.; Hu, S. Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart ;unction. Gene Ther. 15(1):40–48; 2008.
51. Zheng, C.-H.; Gao, J.-Q.; Zhang, Y.-P.; Liang, W.-Q. A protein delivery system: Biodegradable alginate–chitosan–poly (lactic-co-glycolic acid) composite microspheres. BiocheBiochem. Biophys. Res. Commun. 323(4):1321–1327; 2004